company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2928000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2928000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,542000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,350000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,519000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1186000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3153000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3153000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-843000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-432000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-19878000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,317000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,0.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,20634000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-202000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-202000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1333000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2213000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,333000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3213000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3213000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,45000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-217000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q4,2008-10-01,2008-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1510000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1510000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,113000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,67000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-901000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-393000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,396000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q4,2008-10-01,2008-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,396000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-285000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-174000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,247000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,1006000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,231000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q4,2008-10-01,2008-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1025000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q4,2008-10-01,2008-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1025000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-199000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-616000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,230000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-584000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q4,2008-10-01,2008-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-584000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q4,2008-10-01,2008-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-34000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q4,2008-10-01,2008-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,803000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,6243000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6243000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,562000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,254000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-3903000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,551000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3707000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3707000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-941000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-191000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-422000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,536000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,5537000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,560000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5079000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5079000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1917000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2461000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1580000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,211000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2582000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2582000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-29000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6175000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2837000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2837000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,121000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,61000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-3108000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1511000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1422000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1422000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-196000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,75000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,9000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,4048000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,23000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3959000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3959000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1619000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-615000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2233000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2233000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-22000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3126000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-22 11:39:55+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4733000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-22 11:39:55+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4733000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-22 11:39:55+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,449000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-22 11:39:55+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,187000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-22 11:39:55+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-3002000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-22 11:39:55+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,944000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-22 11:39:55+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3311000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-22 11:39:55+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3311000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-22 11:39:55+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-656000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-22 11:39:55+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-191000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-22 11:39:55+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-248000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-22 11:39:55+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,289000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-22 11:39:55+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,4531000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-22 11:39:55+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,329000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-22 11:39:55+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4054000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-22 11:39:55+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4054000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-22 11:39:55+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1718000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-22 11:39:55+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1845000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-22 11:39:55+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1580000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-22 11:39:55+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-22 11:39:55+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-19000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-22 11:39:55+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1998000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-22 11:39:55+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1998000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-22 11:39:55+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,5000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-22 11:39:55+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5372000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-07-23 14:01:55+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1896000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-07-23 14:01:55+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1896000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-07-23 14:01:55+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,328000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-07-23 14:01:55+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,126000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-07-23 14:01:55+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,106000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-07-23 14:01:55+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-567000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-07-23 14:01:55+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1889000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-07-23 14:01:55+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1889000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-07-23 14:01:55+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-460000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-07-23 14:01:55+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-191000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-07-23 14:01:55+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-323000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-07-23 14:01:55+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,280000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-07-23 14:01:55+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,483000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-07-23 14:01:55+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,306000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-07-23 14:01:55+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,95000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-07-23 14:01:55+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,95000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-07-23 14:01:55+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-99000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-07-23 14:01:55+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1230000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-07-23 14:01:55+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1579000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-07-23 14:01:55+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-07-23 14:01:55+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-19000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-07-23 14:01:55+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,235000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-07-23 14:01:55+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,235000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-07-23 14:01:55+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,27000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-07-23 14:01:55+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2246000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,11862000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11862000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,469000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,238000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-8709000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,205000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4065000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4065000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-730000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2793000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3489000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,557000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2075000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4380000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4380000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-238000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2483000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1683000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,827000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,194000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-17000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-17000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,39000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-293000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,8353000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8353000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,121000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,61000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-8726000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1535000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1344000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1344000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-196000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-561000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1171000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,557000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,474000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-130000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1027000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1027000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-105000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-626000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1683000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,42000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,994000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,994000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,5000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1316000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-26 10:29:00+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3509000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-26 10:29:00+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3509000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-26 10:29:00+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,348000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-26 10:29:00+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,177000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-26 10:29:00+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,17000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-26 10:29:00+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1330000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-26 10:29:00+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2721000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-26 10:29:00+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2721000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-26 10:29:00+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-534000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-26 10:29:00+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2232000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-26 10:29:00+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2318000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-26 10:29:00+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1601000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-26 10:29:00+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,130000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-26 10:29:00+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3353000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-26 10:29:00+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3353000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-26 10:29:00+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-133000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-26 10:29:00+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-26 10:29:00+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1857000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-26 10:29:00+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-26 10:29:00+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,785000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-26 10:29:00+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,194000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-26 10:29:00+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1011000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-26 10:29:00+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1011000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-26 10:29:00+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,34000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-26 10:29:00+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1609000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3TTM,2008-10-01,2009-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5019000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5019000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,461000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,244000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-884000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1723000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3117000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3TTM,2008-10-01,2009-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3117000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-819000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2232000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2492000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,247000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,1006000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1832000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,130000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2328000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3TTM,2008-10-01,2009-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2328000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-332000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2473000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,786000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,424000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1595000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3TTM,2008-10-01,2009-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1595000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3TTM,2008-10-01,2009-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-806000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1290000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1290000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,117000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,64000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1473000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1473000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-169000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2232000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-405000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,791000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,26000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1989000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1989000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-36000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-626000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-656000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-656000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,32000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1140000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-22 10:50:12+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2219000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-22 10:50:12+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2219000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-22 10:50:12+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,231000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-22 10:50:12+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,113000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-22 10:50:12+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-22 10:50:12+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1325000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-22 10:50:12+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1248000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-22 10:50:12+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1248000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-22 10:50:12+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-365000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-22 10:50:12+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1913000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-22 10:50:12+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,810000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-22 10:50:12+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,104000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-22 10:50:12+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1364000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-22 10:50:12+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1364000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-22 10:50:12+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-97000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-22 10:50:12+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-22 10:50:12+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1231000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-22 10:50:12+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-22 10:50:12+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,782000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-22 10:50:12+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,191000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-22 10:50:12+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-355000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-22 10:50:12+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-355000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-22 10:50:12+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,2000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-22 10:50:12+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-469000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2TTM,2008-07-01,2009-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,6566000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2TTM,2008-07-01,2009-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6566000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2TTM,2008-07-01,2009-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,465000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2TTM,2008-07-01,2009-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,241000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2TTM,2008-07-01,2009-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-3999000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2TTM,2008-07-01,2009-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-207000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2TTM,2008-07-01,2009-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3066000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2TTM,2008-07-01,2009-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3066000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2TTM,2008-07-01,2009-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-846000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2TTM,2008-07-01,2009-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2012000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2TTM,2008-07-01,2009-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,256000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2TTM,2008-07-01,2009-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,5054000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2TTM,2008-07-01,2009-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1064000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2TTM,2008-07-01,2009-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,104000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2TTM,2008-07-01,2009-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3620000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2TTM,2008-07-01,2009-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3620000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2TTM,2008-07-01,2009-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1915000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2TTM,2008-07-01,2009-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2462000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2TTM,2008-07-01,2009-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2TTM,2008-07-01,2009-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,783000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2TTM,2008-07-01,2009-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,421000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2TTM,2008-07-01,2009-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3172000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2TTM,2008-07-01,2009-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3172000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2TTM,2008-07-01,2009-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-54000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2TTM,2008-07-01,2009-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3460000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1298000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1298000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,121000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,56000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-690000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,796000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,796000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-164000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1043000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,-65000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,730000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,104000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-438000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-438000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-97000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-615000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-2000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-710000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-710000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,27000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-325000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,921000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,921000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,110000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,57000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-635000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,452000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,452000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-201000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-870000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,65000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,80000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-926000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-926000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-616000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,782000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,187000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,355000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,355000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-25000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-144000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,842000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,842000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,259000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-198000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1125000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-433000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1595000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1595000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-125000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-829000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2120000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,-57000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,585000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,67000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2479000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2479000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-927000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-223000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-549000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-54000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,41000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,48000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1664000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1664000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2548000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4513000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4513000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,607000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,389000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1018000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4491000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4491000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-424000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-829000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5823000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3197000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,67000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3812000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3812000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-969000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-576000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2202000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,6000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,252000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,146000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3343000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3343000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,14000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2650000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 12:01:45+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3671000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 12:01:45+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3671000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 12:01:45+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,348000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 12:01:45+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,198000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 12:01:45+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-736000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 12:01:45+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-585000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 12:01:45+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2896000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 12:01:45+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2896000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 12:01:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-299000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 12:01:45+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 12:01:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3703000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 12:01:45+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,57000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 12:01:45+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2612000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 12:01:45+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 12:01:45+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1333000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 12:01:45+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1333000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 12:01:45+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-42000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 12:01:45+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-353000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 12:01:45+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1653000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 12:01:45+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,60000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 12:01:45+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,211000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 12:01:45+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,98000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 12:01:45+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1679000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 12:01:45+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1679000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 12:01:45+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,14000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 12:01:45+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-102000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,12024000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12024000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,469000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,259000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-9462000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,950000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4240000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4240000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-495000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-561000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4874000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,614000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3086000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-130000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2360000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2360000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-147000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-353000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2279000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1743000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,253000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,98000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-685000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-685000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,19000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1214000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1302000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1302000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,102000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,66000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-318000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,231000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1383000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1383000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-89000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-116000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,22000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1131000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,948000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,948000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-42000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-188000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-550000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-7000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,89000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-698000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-698000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,30000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1663000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 10:57:05+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2369000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 10:57:05+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2369000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 10:57:05+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,246000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 10:57:05+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,132000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 10:57:05+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-418000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 10:57:05+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-816000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 10:57:05+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1513000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 10:57:05+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1513000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 10:57:05+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-210000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 10:57:05+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3587000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 10:57:05+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,35000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 10:57:05+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1481000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 10:57:05+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 10:57:05+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2281000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 10:57:05+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2281000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 10:57:05+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 10:57:05+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-165000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 10:57:05+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1103000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 10:57:05+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,67000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 10:57:05+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,122000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 10:57:05+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,98000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 10:57:05+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-981000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 10:57:05+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-981000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 10:57:05+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-16000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 10:57:05+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1765000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,12012000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12012000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,484000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,257000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-9137000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,714000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4330000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4330000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-575000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2793000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5163000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,592000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2746000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-104000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5297000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5297000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-141000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-165000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2355000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1750000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,167000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,101000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-643000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-643000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,21000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1589000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1268000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1268000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,124000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,67000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-297000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-113000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1049000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1049000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-81000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-707000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,-2000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1028000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,238000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,238000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,17000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-165000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-552000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,67000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,40000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,98000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-495000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-495000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-9000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,783000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1101000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1101000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,122000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,65000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-121000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-703000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,464000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,464000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-129000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2880000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,37000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,453000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2519000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2519000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-17000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-551000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,82000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-486000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-486000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-7000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2548000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,12042000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12042000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,481000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,246000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-8829000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,137000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4077000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4077000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-658000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2793000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5499000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,-65000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,594000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2448000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5973000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5973000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-255000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2418000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1681000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,127000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,7000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-858000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-858000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,57000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2697000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1231000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1231000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,146000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,32000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,159000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1568000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1568000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-134000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-50000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1475000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2152000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,2000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,495000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,495000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-362000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-560000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-67000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,236000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-754000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-754000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-4000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1305000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5260000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5260000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,628000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,42000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1090000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4840000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4840000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-367000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-360000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-6819000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5960000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,149000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1437000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1437000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-79000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1221000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2254000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,601000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,296000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2657000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2657000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-3000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,743000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4871000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4871000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,741000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-198000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1135000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1682000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4867000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4867000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-358000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1139000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-7464000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,-57000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4393000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,214000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4411000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4411000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1005000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1082000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2243000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,13000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,406000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,344000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3567000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3567000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3110000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1355000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1355000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,254000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-168000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,813000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-556000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1698000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1698000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-84000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-310000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1157000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1363000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,25000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-163000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-163000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-474000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-564000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-3000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,130000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,207000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-704000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-704000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-25000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,806000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 11:06:28+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4029000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 11:06:28+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4029000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 11:06:28+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,482000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 11:06:28+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 11:06:28+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1249000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 11:06:28+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3272000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 11:06:28+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3272000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 11:06:28+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-233000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 11:06:28+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-310000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 11:06:28+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5344000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 11:06:28+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3808000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 11:06:28+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,147000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 11:06:28+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1932000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 11:06:28+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1932000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 11:06:28+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-78000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 11:06:28+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-859000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 11:06:28+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1694000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 11:06:28+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,67000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 11:06:28+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,365000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 11:06:28+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,296000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 11:06:28+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1903000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 11:06:28+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1903000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 11:06:28+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 11:06:28+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-562000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 11:24:20+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2674000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 11:24:20+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2674000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 11:24:20+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,228000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 11:24:20+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,168000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 11:24:20+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-803000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 11:24:20+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-693000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 11:24:20+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1574000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 11:24:20+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1574000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 11:24:20+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-149000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 11:24:20+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 11:24:20+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4187000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 11:24:20+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,0.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 11:24:20+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2445000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 11:24:20+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,122000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 11:24:20+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1769000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 11:24:20+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1769000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 11:24:20+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-78000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 11:24:20+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-385000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 11:24:20+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1130000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 11:24:20+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,70000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 11:24:20+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,235000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 11:24:20+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,89000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 11:24:20+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1199000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 11:24:20+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1199000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 11:24:20+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,26000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 11:24:20+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1368000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4818000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4818000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,589000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,36000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-895000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4552000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4552000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-363000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-829000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-6423000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,-35000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4161000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,189000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3300000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3300000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1047000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-796000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2229000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,9000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,365000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,137000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3561000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3561000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,56000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2253000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1307000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1307000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,111000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,95000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-745000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,325000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1093000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1093000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-74000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1953000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,-114000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1687000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,122000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-332000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-332000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-24000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-237000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-565000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,52000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,182000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,85000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-507000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-507000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,6000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,260000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4779000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4779000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,602000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,8000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,452000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1333000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4508000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4508000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-370000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-829000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5177000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,77000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3502000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,67000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2730000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2730000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1006000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-724000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2216000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,24000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,223000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,150000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3549000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3549000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,41000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1730000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1367000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1367000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,117000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,73000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-58000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1018000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,481000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,481000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-75000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2234000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,114000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,758000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1437000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1437000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-54000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-148000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-565000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,18000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,53000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-692000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-692000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,20000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1628000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,924000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,924000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,199000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,292000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,52000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-631000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,836000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,836000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-175000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-106000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,68000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,506000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-16000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,277000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,277000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-492000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-561000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,29000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,66000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-958000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-958000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,153000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2501000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2501000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,681000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,292000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5869000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2402000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6941000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6941000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-548000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-7530000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3607000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,68000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4890000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6727000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6727000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2108000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2403000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2286000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1999000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,463000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4333000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4333000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4120000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2808000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2808000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,628000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5849000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1612000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,7673000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,7673000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-507000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-7580000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4976000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6536000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,18000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6509000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6509000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2109000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2273000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2285000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1903000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,633000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4129000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4129000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-3000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2968000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-713000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-713000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,195000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5434000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-332000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4584000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4584000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-137000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-5039000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-75000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1047000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4203000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4203000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1999000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1051000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-571000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1849000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,83000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1689000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1689000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,10000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1298000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-23 10:50:53+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1577000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-23 10:50:53+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1577000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-23 10:50:53+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,482000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-23 10:50:53+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5817000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-23 10:50:53+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1771000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-23 10:50:53+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6105000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-23 10:50:53+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6105000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-23 10:50:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-373000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-23 10:50:53+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-7530000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-23 10:50:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3501000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-23 10:50:53+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4384000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-23 10:50:53+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,16000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-23 10:50:53+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7004000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-23 10:50:53+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7004000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-23 10:50:53+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2108000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-23 10:50:53+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1911000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-23 10:50:53+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1725000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-23 10:50:53+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1970000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-23 10:50:53+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,397000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-23 10:50:53+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-23 10:50:53+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3375000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-23 10:50:53+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3375000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-23 10:50:53+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-10-23 10:50:53+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4273000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4876000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4876000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,687000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-168000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1228000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1836000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4787000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4787000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-454000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2851000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-6058000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6852000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,42000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2469000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2469000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-110000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1696000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2278000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,51000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,680000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,209000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3144000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3144000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-38000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-864000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,808000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,808000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,148000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,233000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-55000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1134000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1134000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-113000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-811000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1147000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,3000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,226000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,226000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-521000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-575000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,91000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,155000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-850000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-850000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-16000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,494000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-25 11:31:51+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2290000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-25 11:31:51+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2290000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-25 11:31:51+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,287000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-25 11:31:51+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,383000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-25 11:31:51+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1439000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-25 11:31:51+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1521000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-25 11:31:51+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1521000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-25 11:31:51+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-236000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-25 11:31:51+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2491000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-25 11:31:51+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3426000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-25 11:31:51+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3337000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-25 11:31:51+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,15000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-25 11:31:51+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2801000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-25 11:31:51+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2801000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-25 11:31:51+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-109000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-25 11:31:51+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-860000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-25 11:31:51+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1154000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-25 11:31:51+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,121000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-25 11:31:51+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,314000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-25 11:31:51+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-25 11:31:51+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1686000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-25 11:31:51+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1686000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-25 11:31:51+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-9000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-07-25 11:31:51+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2975000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5375000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5375000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,650000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-73000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,250000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1456000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4746000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4746000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-415000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2851000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-7200000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,-114000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7392000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,161000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3027000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3027000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-134000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1412000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2268000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,12000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,707000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,294000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2801000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2801000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-16000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1098000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1482000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1482000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,139000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,150000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1384000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,387000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,387000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-123000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2491000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2615000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2190000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,12000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3027000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3027000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-109000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-339000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-579000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,30000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,159000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-836000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-836000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,7000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3469000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2580000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2580000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,763000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,294000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,222000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-314000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3545000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3545000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-537000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1859000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,9000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1815000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-572000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-572000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-597000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-433000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2309000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1687000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,564000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,20000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1068000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1068000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,25000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1930000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,735000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,735000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,181000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,294000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,87000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,113000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1410000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1410000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-200000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-411000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,1000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,295000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-315000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-315000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-577000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1187000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,81000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,20000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,711000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,711000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,9000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1815000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2769000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2769000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,781000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,292000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,187000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1058000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2971000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2971000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-512000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1554000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,76000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2026000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-16000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,20000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,20000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-597000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-925000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2293000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,529000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,549000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2737000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2737000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,14000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,268000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,692000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,692000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,180000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,47000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,134000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1053000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1053000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-124000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-598000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,8000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,242000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-475000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-475000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-518000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-53000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-577000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,488000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,40000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-620000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-620000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-8000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-50000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 11:16:25+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1845000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 11:16:25+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1845000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 11:16:25+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,582000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 11:16:25+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,135000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 11:16:25+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-427000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 11:16:25+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2135000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 11:16:25+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2135000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 11:16:25+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-337000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 11:16:25+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1448000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 11:16:25+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,8000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 11:16:25+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1520000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 11:16:25+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-257000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 11:16:25+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-257000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 11:16:25+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-597000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 11:16:25+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-433000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 11:16:25+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1732000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 11:16:25+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,500000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 11:16:25+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,483000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 11:16:25+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1779000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 11:16:25+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1779000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 11:16:25+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,16000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-24 11:16:25+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,115000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1364000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1364000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,796000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,292000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5574000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1524000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6502000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6502000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-525000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-5039000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1031000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,68000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2831000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-12000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3708000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3708000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2078000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1923000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2287000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1890000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,592000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3806000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3806000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,32000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-980000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,530000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,530000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,189000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,39000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,752000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1510000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1510000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-98000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-572000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,727000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,57000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,57000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-79000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-83000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-575000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-551000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,173000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1115000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1115000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,14000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,466000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-24 11:18:20+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1153000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-24 11:18:20+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1153000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-24 11:18:20+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,402000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-24 11:18:20+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,88000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-24 11:18:20+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-561000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-24 11:18:20+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1082000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-24 11:18:20+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1082000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-24 11:18:20+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-213000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-24 11:18:20+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-850000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-24 11:18:20+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1278000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-24 11:18:20+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,3000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-24 11:18:20+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,218000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-24 11:18:20+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,218000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-24 11:18:20+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-79000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-24 11:18:20+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-380000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-24 11:18:20+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1155000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-24 11:18:20+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,12000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-24 11:18:20+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,443000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-24 11:18:20+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1159000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-24 11:18:20+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1159000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-24 11:18:20+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,24000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-24 11:18:20+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,165000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1642000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1642000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,755000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,292000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5768000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2331000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6126000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6126000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-540000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-5039000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1270000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,68000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3251000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-9000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3539000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3539000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1999000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2361000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2287000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2532000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,574000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3541000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3541000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,2000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-952000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,623000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,623000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,213000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,49000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1313000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-428000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-428000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-115000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-278000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,551000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,3000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,161000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,161000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-297000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-580000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,563000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,270000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-44000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-44000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,10000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-301000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2029000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2029000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,467000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,971000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-19000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-300000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3148000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3148000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-526000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-219000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5719000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,3585000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4095000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1216000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1216000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-676000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2398000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,244000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,288000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,105000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2437000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2437000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,58000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1985000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,27000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,27000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,103000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,765000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-333000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,572000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,572000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-191000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-6000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-908000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,132000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1324000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,351000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,351000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-598000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,199000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,59000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,109000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-231000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-231000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,28000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,720000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-27 12:36:09+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2002000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-27 12:36:09+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2002000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-27 12:36:09+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,364000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-27 12:36:09+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,206000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-27 12:36:09+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-29000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-27 12:36:09+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,33000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-27 12:36:09+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2576000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-27 12:36:09+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2576000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-27 12:36:09+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-335000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-27 12:36:09+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-213000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-27 12:36:09+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4811000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-27 12:36:09+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,3453000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-27 12:36:09+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2771000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-27 12:36:09+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,865000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-27 12:36:09+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,865000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-27 12:36:09+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-676000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-27 12:36:09+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1800000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-27 12:36:09+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,45000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-27 12:36:09+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,229000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-27 12:36:09+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-4000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-27 12:36:09+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2206000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-27 12:36:09+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2206000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-27 12:36:09+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,30000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-27 12:36:09+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1265000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2737000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2737000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,545000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,500000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,58000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,146000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3986000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3986000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-535000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-213000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5222000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,3454000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3066000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,550000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,550000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-676000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2377000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1232000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,310000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,16000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1495000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1495000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,39000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3080000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,732000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,732000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,112000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,54000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-289000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,294000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,903000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,903000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-107000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1803000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,241000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1833000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,164000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,164000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-597000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,40000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,29000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-528000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-528000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,30000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,569000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-23 11:35:16+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1270000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-23 11:35:16+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1270000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-23 11:35:16+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,252000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-23 11:35:16+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,152000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-23 11:35:16+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,260000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-23 11:35:16+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-261000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-23 11:35:16+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1673000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-23 11:35:16+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1673000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-23 11:35:16+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-228000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-23 11:35:16+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-213000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-23 11:35:16+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3008000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-23 11:35:16+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,3212000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-23 11:35:16+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,938000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-23 11:35:16+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,701000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-23 11:35:16+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,701000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-23 11:35:16+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-676000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-23 11:35:16+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1203000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-23 11:35:16+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-23 11:35:16+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,200000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-23 11:35:16+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-4000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-23 11:35:16+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1678000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-23 11:35:16+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1678000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-23 11:35:16+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,696000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2697000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2697000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,613000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,446000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,394000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-14000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4136000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4136000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-552000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-213000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4017000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,3221000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1475000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-89000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-89000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1194000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-53000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2357000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1680000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,321000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,16000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1587000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1587000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2461000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,334000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,334000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,115000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,72000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,426000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,109000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1056000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1056000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-110000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-192000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1928000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,157000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,562000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1511000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1511000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,79000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-598000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,28000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-486000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-486000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-943000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,936000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,936000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,137000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,80000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-166000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-370000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,617000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,617000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-118000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-21000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1080000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,3055000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,376000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2212000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2212000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-755000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-605000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,172000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-4000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1192000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1192000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,2000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1639000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2893000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2893000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,687000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,374000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,629000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4590000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4590000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-540000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-21000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2661000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,3064000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1640000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1479000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1479000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1352000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-136000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2334000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1124000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,466000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,16000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2216000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2216000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,17000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3870000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1631000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1631000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,376000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,245000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,935000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1082000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2105000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2105000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-820000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1111000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3143000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,708000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2794000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1572000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1572000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2415000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2477000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1268000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3624000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3624000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-95000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3186000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-188000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-188000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,76000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,67000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,504000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,425000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,884000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,884000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-285000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-219000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-860000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,35000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,345000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-984000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-984000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-458000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-618000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-54000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-231000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1359000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1359000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-131000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1590000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 11:35:27+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1819000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 11:35:27+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1819000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 11:35:27+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,300000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 11:35:27+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,178000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 11:35:27+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,431000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 11:35:27+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1507000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 11:35:27+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1221000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 11:35:27+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1221000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 11:35:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-535000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 11:35:27+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-892000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 11:35:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2283000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 11:35:27+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,673000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 11:35:27+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2449000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 11:35:27+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-588000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 11:35:27+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-588000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 11:35:27+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1957000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 11:35:27+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1859000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 11:35:27+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1322000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 11:35:27+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,231000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 11:35:27+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-2000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 11:35:27+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2265000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 11:35:27+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2265000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 11:35:27+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,36000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 11:35:27+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1596000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1846000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1846000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,403000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,943000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,441000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1840000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1793000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1793000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-726000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-898000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3191000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,805000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3773000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-237000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-237000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1957000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2457000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1521000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,290000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,107000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2496000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2496000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,64000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-876000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,730000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,730000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,105000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,68000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-316000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-63000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,524000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,524000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-234000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-37000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-811000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,379000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,641000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-62000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-62000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-617000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-113000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,30000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-700000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-700000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,14000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-224000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 11:32:27+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1089000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 11:32:27+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1089000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 11:32:27+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,195000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 11:32:27+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,110000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 11:32:27+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,747000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 11:32:27+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1444000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 11:32:27+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,697000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 11:32:27+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,697000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 11:32:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-301000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 11:32:27+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-855000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 11:32:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1472000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 11:32:27+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,294000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 11:32:27+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1808000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 11:32:27+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-526000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 11:32:27+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-526000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 11:32:27+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1957000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 11:32:27+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1242000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 11:32:27+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1435000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 11:32:27+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,201000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 11:32:27+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-2000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 11:32:27+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1565000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 11:32:27+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1565000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 11:32:27+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,22000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 11:32:27+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1372000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1848000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1848000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,410000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,929000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,468000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1483000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2172000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2172000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-599000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-861000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4183000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,667000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4965000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-11000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-11000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1957000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2437000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1674000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,289000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,107000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2324000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2324000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,80000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-83000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-110000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-110000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,91000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,60000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,935000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-905000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,71000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,71000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-165000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-855000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-651000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,91000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,300000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1280000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1280000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1697000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-619000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1435000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,27000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-29000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-883000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-883000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-3000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2095000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1199000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1199000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,104000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,50000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-188000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-539000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,626000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,626000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-136000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-821000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,203000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1508000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,754000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,754000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-260000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-623000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,174000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,27000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-682000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-682000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,25000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,723000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2292000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2292000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,434000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,941000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-41000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-469000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3157000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3157000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-544000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-198000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5460000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,733000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5227000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-242000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-242000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-181000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2416000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,244000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,290000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,136000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1927000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1927000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,81000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1069000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4507000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4507000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,382000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,169000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-644000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1356000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3058000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3058000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1215000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-359000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3089000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,1334000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4809000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1480000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1480000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-15000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-231000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2547000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,140000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2653000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2653000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-33000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1852000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,898000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,898000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,122000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,47000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-4000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,380000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1443000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1443000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-371000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-48000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-841000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,141000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1135000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,16000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,16000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-8000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-635000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,38000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-605000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-605000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-49000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,805000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 11:27:47+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3609000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 11:27:47+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3609000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 11:27:47+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,260000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 11:27:47+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,122000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 11:27:47+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-640000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 11:27:47+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1736000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 11:27:47+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1615000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 11:27:47+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1615000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 11:27:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-844000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 11:27:47+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-311000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 11:27:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2248000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 11:27:47+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,1193000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 11:27:47+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3674000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 11:27:47+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1464000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 11:27:47+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1464000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 11:27:47+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-7000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 11:27:47+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-231000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 11:27:47+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1912000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 11:27:47+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,102000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 11:27:47+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2048000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 11:27:47+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2048000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 11:27:47+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,16000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-26 11:27:47+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1047000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3421000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3421000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,336000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,189000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-136000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1311000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2499000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2499000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1129000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-530000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3108000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,1228000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4019000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,480000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,480000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-465000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-231000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2530000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,48000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-231000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3407000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3407000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-115000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-543000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1215000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1215000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,105000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,39000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-97000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,142000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1404000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1404000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-341000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-44000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1053000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,190000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,880000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-368000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-368000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,5000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-636000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,85000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-546000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-546000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,8000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,498000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 11:23:30+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2394000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 11:23:30+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2394000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 11:23:30+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,155000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 11:23:30+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,83000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 11:23:30+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-543000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 11:23:30+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1878000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 11:23:30+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,211000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 11:23:30+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,211000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 11:23:30+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-503000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 11:23:30+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-267000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 11:23:30+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1195000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 11:23:30+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,1003000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 11:23:30+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2794000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 11:23:30+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1832000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 11:23:30+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1832000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 11:23:30+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-12000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 11:23:30+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-231000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 11:23:30+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1276000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 11:23:30+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,17000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 11:23:30+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1502000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 11:23:30+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1502000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 11:23:30+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,8000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-27 11:23:30+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,549000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2936000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2936000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,336000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,218000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-355000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1516000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1619000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1619000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1022000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-523000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2866000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,1417000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3780000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,786000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,786000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-470000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-231000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2511000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-150000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-201000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3561000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3561000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-109000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1265000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1188000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1188000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,90000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,44000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-192000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-691000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,439000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,439000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-261000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-259000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-672000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,564000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1034000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,406000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,406000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,66000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-635000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,17000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-552000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-552000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-3000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,290000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1206000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1206000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,65000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,39000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-351000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1187000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-228000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-228000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-242000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-8000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-523000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,439000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1760000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1426000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1426000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-78000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-231000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-641000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-950000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-950000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,11000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,259000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1638000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1638000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,337000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,234000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,772000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1730000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1251000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1251000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-926000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1119000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2845000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,944000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3046000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-900000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-900000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2233000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-231000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2495000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1268000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-174000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-27000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3892000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3892000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-109000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3650000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,975000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,975000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,789000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,236000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,677000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2598000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5275000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5275000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1055000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-726000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5419000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,736000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6398000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-66000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-66000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1246000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2469000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2577000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2215000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4077000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4077000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1132000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2329000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2329000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,197000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,88000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,233000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2928000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1117000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1117000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-254000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-54000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-985000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,210000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2102000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1019000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1019000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,7000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-249000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-639000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-471000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1352000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1352000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-59000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,725000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 11:36:04+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3304000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 11:36:04+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3304000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 11:36:04+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,592000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 11:36:04+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,148000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 11:36:04+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,444000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 11:36:04+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-330000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 11:36:04+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4158000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 11:36:04+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4158000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 11:36:04+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-801000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 11:36:04+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-672000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 11:36:04+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4434000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 11:36:04+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,526000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 11:36:04+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4296000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 11:36:04+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1085000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 11:36:04+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1085000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 11:36:04+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1253000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 11:36:04+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2220000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 11:36:04+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1938000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 11:36:04+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2686000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 11:36:04+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2725000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 11:36:04+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2725000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 11:36:04+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,59000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 11:36:04+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,407000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4202000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4202000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,714000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,195000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,440000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,50000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5601000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5601000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1172000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-720000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5275000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,667000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5431000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1069000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1069000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1261000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2220000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2573000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2724000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3330000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3330000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,10000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1212000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,856000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,856000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,188000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,41000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,238000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,390000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1713000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1713000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-262000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-353000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1393000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,137000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2013000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,142000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,142000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-744000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-220000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-640000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,898000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-706000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-706000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,25000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1174000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 11:32:21+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2448000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 11:32:21+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2448000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 11:32:21+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,404000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 11:32:21+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,107000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 11:32:21+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,206000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 11:32:21+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-720000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 11:32:21+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2445000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 11:32:21+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2445000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 11:32:21+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-539000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 11:32:21+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-319000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 11:32:21+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3041000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 11:32:21+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,389000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 11:32:21+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2283000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 11:32:21+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1227000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 11:32:21+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1227000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 11:32:21+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-509000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 11:32:21+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2000000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 11:32:21+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1298000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 11:32:21+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1788000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 11:32:21+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2019000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 11:32:21+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2019000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 11:32:21+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,34000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 11:32:21+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-767000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4561000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4561000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,631000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,193000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,105000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-198000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5292000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5292000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1251000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-411000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4935000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,720000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4298000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1579000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1579000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-512000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2000000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2569000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1911000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3170000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3170000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-7000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,536000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,922000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,922000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,211000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,55000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,326000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,70000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1584000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1584000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-248000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-207000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1837000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,148000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1120000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1024000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1024000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-471000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-643000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,108000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1006000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1006000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,6000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-440000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1526000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1526000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,193000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,52000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-120000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-790000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,861000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,861000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-291000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-112000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1204000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,241000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1163000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-203000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-203000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-38000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2000000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-655000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1680000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1013000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1013000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,28000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-327000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4827000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4827000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,510000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,182000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-413000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-959000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4147000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4147000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1264000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-463000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3770000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,1136000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4212000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-149000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-149000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,25000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2000000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2561000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1820000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2716000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2716000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-16000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1266000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4947000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4947000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,637000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,186000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-92000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,262000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5940000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5940000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-951000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1246000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2305000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,1249000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2379000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-874000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-874000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-602000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-320000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2613000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3535000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3535000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1531000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1158000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1158000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,172000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,41000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,166000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,892000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2429000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2429000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-290000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-31000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1243000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,302000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,926000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-336000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-336000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,75000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-653000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-578000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-578000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,29000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1544000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 09:39:45+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3789000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 09:39:45+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3789000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 09:39:45+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,465000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 09:39:45+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,145000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 09:39:45+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-258000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 09:39:45+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-630000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 09:39:45+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3511000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 09:39:45+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3511000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 09:39:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-661000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 09:39:45+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1215000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 09:39:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1062000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 09:39:45+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,947000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 09:39:45+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1453000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 09:39:45+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-538000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 09:39:45+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-538000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 09:39:45+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-677000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 09:39:45+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-320000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 09:39:45+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1960000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 09:39:45+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 09:39:45+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2957000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 09:39:45+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2957000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 09:39:45+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-29000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 09:39:45+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-13000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1460000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1460000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,662000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,233000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-25000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2298000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4628000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4628000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-915000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1269000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2047000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,1157000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3555000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,481000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,481000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-670000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-569000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2599000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-471000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4309000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4309000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-88000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,712000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1912000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1912000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,165000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,41000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-370000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-469000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1279000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1279000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-224000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-45000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-615000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,364000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,373000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-147000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-147000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-67000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-653000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-720000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-720000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-3000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,409000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-25 11:33:59+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1877000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-25 11:33:59+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1877000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-25 11:33:59+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,300000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-25 11:33:59+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,104000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-25 11:33:59+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,112000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-25 11:33:59+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-161000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-25 11:33:59+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2232000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-25 11:33:59+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2232000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-25 11:33:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-437000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-25 11:33:59+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1170000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-25 11:33:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-447000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-25 11:33:59+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,583000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-25 11:33:59+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1080000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-25 11:33:59+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-391000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-25 11:33:59+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-391000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-25 11:33:59+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-610000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-25 11:33:59+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-320000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-25 11:33:59+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1307000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-25 11:33:59+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-25 11:33:59+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2237000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-25 11:33:59+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2237000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-25 11:33:59+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-26000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-25 11:33:59+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-422000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,404000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,404000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,685000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,233000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,583000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3157000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5062000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5062000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-953000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1577000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2825000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,930000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5195000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,770000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,770000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1347000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-789000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2586000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,427000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4295000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4295000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-60000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1477000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,382000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,382000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,157000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,54000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,201000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,263000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1057000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1057000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-198000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-834000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-162000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,208000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,638000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-348000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-348000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-208000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-153000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-654000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1015000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1015000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-37000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-343000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1495000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1495000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,143000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,50000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-89000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-424000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1175000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1175000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-239000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-336000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-285000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,375000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,442000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-43000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-43000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-402000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-167000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-653000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1222000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1222000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,11000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-79000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,944000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,944000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,739000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,234000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,708000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2964000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5589000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5589000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1003000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-950000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4500000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,870000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5677000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,94000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,94000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1610000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-636000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2575000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,535000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4286000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4286000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-17000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1380000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1060000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1060000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1236000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,5000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-174000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2031000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2038000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2038000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-251000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-24576000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2319000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,13765000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1345000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-12036000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-12036000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-8013000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-7000000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-668000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,8004000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-7677000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-7677000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,15000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-17660000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3460000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3460000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1746000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1688000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1491000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2664000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,8067000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,8067000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-836000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-24634000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3961000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,15852000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3809000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9770000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9770000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-9309000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-7300000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2679000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,26909000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7621000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7621000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5918000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5678000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5678000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,682000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1724000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1151000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1525000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,8458000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,8458000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-875000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-89000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2885000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,2389000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3390000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1930000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1930000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1221000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-300000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2664000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,18905000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,14720000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,14720000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,14000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,25122000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1366000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1366000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,171000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1557000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1037000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,499000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2556000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2556000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-190000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-9000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1205000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,1719000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,176000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,491000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,491000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-300000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-671000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,31000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-941000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-941000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-21000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2085000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 09:39:45+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4520000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 09:39:45+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4520000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 09:39:45+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,510000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 09:39:45+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1683000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 09:39:45+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1317000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 09:39:45+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,633000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 09:39:45+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6029000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 09:39:45+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6029000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 09:39:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-585000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 09:39:45+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-58000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 09:39:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1642000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 09:39:45+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,2087000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 09:39:45+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2464000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 09:39:45+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2266000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 09:39:45+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2266000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 09:39:45+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1296000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 09:39:45+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-300000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 09:39:45+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2011000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 09:39:45+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,18905000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 09:39:45+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,15298000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 09:39:45+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,15298000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 09:39:45+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-15000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 09:39:45+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,23578000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,6224000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6224000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,676000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,208000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-484000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,557000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,7181000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,7181000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-909000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-125000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2295000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,1034000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3587000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1292000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1292000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1287000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2646000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,18874000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,14941000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,14941000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,32000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,23446000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1439000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1439000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,169000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,60000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-31000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,446000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2083000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2083000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-191000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-34000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-195000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,58000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1077000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,715000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,715000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,65000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-671000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,18874000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,18268000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,18268000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,6000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,21072000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-25 11:33:59+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3154000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-25 11:33:59+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3154000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-25 11:33:59+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,339000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-25 11:33:59+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,126000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-25 11:33:59+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-280000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-25 11:33:59+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,134000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-25 11:33:59+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3473000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-25 11:33:59+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3473000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-25 11:33:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-395000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-25 11:33:59+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-49000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-25 11:33:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-437000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-25 11:33:59+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,368000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-25 11:33:59+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2288000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-25 11:33:59+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1775000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-25 11:33:59+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1775000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-25 11:33:59+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1295000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-25 11:33:59+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-25 11:33:59+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1340000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-25 11:33:59+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,18874000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-25 11:33:59+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,16239000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-25 11:33:59+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,16239000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-25 11:33:59+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,6000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-25 11:33:59+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,21493000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1715000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1715000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,170000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,66000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-249000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-312000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1390000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1390000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-204000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-15000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-242000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,310000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1211000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1060000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1060000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1360000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-669000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2029000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2029000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,421000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5167000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5167000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,664000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,202000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-252000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,374000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6155000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6155000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-916000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-925000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2262000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,1184000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3148000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,229000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,229000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1560000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-153000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2629000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4342000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4342000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-11000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2031000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,979000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,979000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4053000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1633000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-855000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4761000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,10571000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,10571000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-818000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-24644000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4454000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,15747000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3992000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10177000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10177000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-7949000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-7381000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-3027000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,26953000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8596000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,8596000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,8990000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-766000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-766000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2477000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,11000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,387000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1785000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3894000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3894000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-186000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-25000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-735000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,205000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1394000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,653000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,653000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-81000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1017000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,44000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1054000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1054000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3493000000.0
